Press release
Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Anticipated To Witness Robust Growth, Surpassing $18.54 Billion By 2029
Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market
What Is the Current Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Size and Its Estimated Growth Rate?
The cell and gene therapy contract development and manufacturing organization (CDMO) market has grown exponentially. It is forecast to increase from $5.41 billion in 2024 to $6.94 billion in 2025, at a CAGR of 28.2%. This growth is fueled by technological advancements, favorable regulatory frameworks, increased investment, a high prevalence of genetic disorders, and a rise in strategic partnerships.
The cell and gene therapy contract development and manufacturing organization (CDMO) market is expected to grow exponentially, reaching $18.54 billion by 2029, at a CAGR of 27.8%. Growth is due to expanded therapeutic applications, regulatory changes, investments, and global collaboration. Trends include personalized therapy demand, automation, manufacturing capacity growth, novel delivery systems, and sustainability focus.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15753
How Are Emerging Segments Shaping the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Landscape?
The cell and gene therapy contract development and manufacturing organization (CDMO) market covered in this report is segmented -
1) By Product Type: Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy
2) By Phase: Phase 1, Phase 2, Phase 3, Phase 4
3) By Indication: Oncology, Infectious Diseases, Neurological Disorders, Rare Diseases, Other Indications
Subsegments:
1) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Gene Therapy, Plasmid DNA-Based Gene Therapy
2) By Gene-Modified Cell Therapy: CAR-T Cell Therapy, TCR-T Cell Therapy, NK Cell Therapy
3) By Cell Therapy: Stem Cell Therapy, Progenitor Cell Therapy, Immune Cell Therapy
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15753&type=smp
Which Growth Factors Are Influencing Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Expansion?
The increasing incidence of cancer is expected to boost the growth of the cell and gene therapy contract development and manufacturing organization (CDMO) market. The rise in cancer cases is due to aging populations, changing lifestyles, environmental exposures, and enhanced diagnostic methods. CDMOs support cancer treatment development by producing targeted therapies that improve effectiveness and patient outcomes. According to a 2022 report by Macmillan Cancer Support, the number of people living with cancer in the UK is projected to grow significantly, reaching 5.3 million by 2040. This increase in cancer prevalence is contributing to the growth of the CDMO market.
Who Are the Dominant Players Across Different Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Segments?
Major companies operating in the cell and gene therapy contract development and manufacturing organization (CDMO) market are Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, FUJIFILM Diosynth Biotechnologies, AGC Biologics, Ajinomoto Co Inc., Lonza Group, Catalent Inc., Charles River Laboratories International Inc., Sartorius Stedim Biotech, Samsung Biologics Co Ltd., WuXi Biologics, Recipharm AB, Almac Group Ltd., KBI Biopharma, Rentschler Biopharma, Bio Elpida, Oxford BioMedica Plc, Avid Bioservices Inc., Cell and Gene Therapy Catapult, VGXI Inc., Genezen Laboratories Inc., Pluri Inc., OmniaBio Inc.
What Trends Are Expected to Dominate the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market in the Next 5 Years?
Companies in the cell and gene therapy contract development and manufacturing organization (CDMO) market are expanding their offerings with advanced solutions like PluriMatrix technology to improve scalability, efficiency, and quality in cell-based product manufacturing. PluriMatrix facilitates 3D cell expansion, ensuring high yield and quality. In January 2024, Pluri launched PluriCDMO, a division offering cell therapy manufacturing services, including a GMP-compliant production facility. This division leverages PluriMatrix technology to provide end-to-end services in cell therapy production.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-contract-development-and-manufacturing-organization-cdmo-global-market-report
Which Geographic Regions Are Expected to Dominate the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market in the Coming Years?
North America was the largest region in the cell and gene therapy contract development and manufacturing organization (CDMO) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
2. What is the CAGR expected in the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
3. What Are the Key Innovations Transforming the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Industry?
4. Which Region Is Leading the Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Anticipated To Witness Robust Growth, Surpassing $18.54 Billion By 2029 here
News-ID: 4034891 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Therapy
Music Therapy Market Growth Potential is Booming Now: World Federation of Music …
HTF MI just released the Global Music Therapy Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2033. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies in Music Therapy Market are: Music Therapy Services (United…
Visual Arts Therapy Market Future Business Opportunities 2024-2031 | American Ar …
A recent report titled "Visual Arts Therapy Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report additionally features a comprehensive table of contents, figures, tables, and charts, as well as an analysis of the data. The Visual…
Hair Transplant Market by Therapy (Platelet-Rich Plasma Therapy (PRP), Stem Cell …
Hair transplant refers to the market for surgical procedures aimed at restoring hair growth in individuals experiencing hair loss or baldness. These procedures involve the transplantation of hair follicles from one part of the body to the balding or thinning areas.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-hair-transplant-market
The expansion of biotechnology sector across the globe, acts as one of the major factors driving the growth of global hair transplant market. The increase in the…
Melanoma Therapeutics Market By Chemotherapy, Biologic therapy, Targeted therapy …
Melanoma market has witnessed an unprecedented boost in market size, owing to a dynamically evolving nature of melanoma treatments over the past few years. The high demand of novel early stage and advanced melanoma therapies along with a booming patient base, has created an impending need for better therapies in the melanoma market. Although, a plethora of treatment options are available today, several immunotherapies and combination therapies are expected to…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights:
• Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026
• Cell Therapy Clinical Trial Insight by Indication, Company & Country
• Global Cell Therapy Clinical Pipeline: 767 Cell Therapies
• Globally Marketed Cell Therapies: 25 Cell Therapies
• Maximum Number of Marketed Cell Therapies In USA: 15 Therapies
• Price & Product Insight By Region/Country
• Regional Analysis of the Cell Therapy Market
Download…
